J. Biol. Chem., Vol. 263, Issue 15, 7170-7175, May, 1988

Organization and differential expression of two highly similar genes in the rabbit alcohol-inducible cytochrome P-450 subfamily

SC Khani, TD Porter, VS Fujita and MJ Coon
Department of Biological Chemistry, Medical School, University of Michigan, Ann Arbor 48109.

The exon-intron organization of two rabbit genes that hybridize with cytochrome P-450 3a (P-450ALC) cDNA has been determined by restriction mapping and sequence analysis. Gene 1 encodes cytochrome P-450 3a as judged by the complete identity of its coding nucleotide sequence with P-450 3a cDNA. Gene 2 encodes a previously uncharacterized cytochrome P- 450 that is 97% identical in primary structure to P-450 3a, with 16 amino acid differences scattered throughout the protein. Genes 1 and 2, which are 10 and 9 kilobases in length, respectively, are comprised of 9 exons with exon-intron junctions occurring at identical positions along the mRNA sequences. Each gene contains two transcription start sites approximately 27 and 33 nucleotides upstream from the translation initiation codon, as determined by primer extension and S1 nuclease protection experiments. The predicted lengths of gene 1 and 2 transcripts from the first transcription start site to the poly(A) attachment site are 1999 and 1660 nucleotides, respectively. This difference in size is primarily the result of a 338-base pair deletion in the 3' nontranslated portion of the gene 2 transcript relative to that of gene 1. The two genes show considerable similarity in their 5' flanking regions, including a "TATAA" transcriptional promoter element at position -28. However, a 32-base pair element that is repeated in gene 1 is present only as a single inexact copy in gene 2. By use of synthetic oligonucleotides as hybridization probes, gene 2 transcripts were shown to be present in poly(A)+ RNA from untreated rabbit liver at approximately 50% of P-450 3a mRNA levels. In kidney, however, no gene 2 mRNA was detected although 3a mRNA was present at approximately 10% of the level in liver.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. D. Porter JUD COON: 35 YEARS OF P450 RESEARCH, A SYNOPSIS OF P450 HISTORY Drug Metab. Dispos., January 1, 2004; 32(1): 1 - 6. [Abstract] [Full Text] [PDF]

				J. E. Young, T. Vogt, K. W. Gross, and S. C. Khani A Short, Highly Active Photoreceptor-Specific Enhancer/Promoter Region Upstream of the Human Rhodopsin Kinase Gene Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4076 - 4085. [Abstract] [Full Text] [PDF]

				S. M. Lankford, S. A. Bai, and J. A. Goldstein Cloning of Canine Cytochrome P450 2E1 cDNA: Identification and Characterization of Two Variant Alleles Drug Metab. Dispos., August 1, 2000; 28(8): 981 - 986. [Abstract] [Full Text]

				H.-M. Peng and M. J. Coon Regulation of Rabbit Cytochrome P450 2E1 Expression in HepG2 Cells by Insulin and Thyroid Hormone Mol. Pharmacol., October 1, 1998; 54(4): 740 - 747. [Abstract] [Full Text]

				J. W. Lohr, G. R. Willsky, and M. A. Acara Renal Drug Metabolism Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142. [Abstract] [Full Text] [PDF]

				Y. Hu, M. Oscarson, I. Johansson, Q.-Y. Yue, M.-L. Dahl, M. Tabone, S. Arinco, E. Albano, and M. Ingelman-Sundberg Genetic Polymorphism of Human CYP2E1: Characterization of Two Variant Alleles Mol. Pharmacol., March 1, 1997; 51(3): 370 - 376. [Abstract] [Full Text] [PDF]